16 articles for DS Williamson
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.
Vernalis (R&D)
Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Vernalis (R&D)
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
Vernalis (R&D)
Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Vernalis (R&D)
The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors.
H. Lundbeck
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).
Vernalis (R&D)
Substituted pyridine derivatives useful as c-fms kinase inhibitors
Janssen Pharmaceutica
Substituted 2-azabicycles and their use as orexin receptor modulators
Janssen Pharmaceutica
In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Universidad De Santiago De Chile
Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.
Novartis Pharmaceuticals
Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.
Johnson & Johnson Pharmaceutical